维普中文期刊产品整合服务
26篇 您的检索式:作者名="Cohen MW"
    题名 作者 年代 出处 被引量
1Early life menstrual charac- teristics and pregnancy experiences among women with and without major depression: the Harvard study of moods and cycles 显示文摘Harlow BL Cohen LS Otto MW 2004J Af- fect Disord2004,79,13:1
2Growth factors rescue embryonic dopamine neurons from programmed cell death 显示文摘Zawada MW Kirdchman DL Cohen JJ 1996Exp Neurol1996,140,1:1
3Early appearance of neuronal contribution to agrin-like molecules at embryonic frog nerve-muscle synapses formed in culture显示文摘Cohen MW Godfrey EW 1992J Neurosci1992,12,8:1
4Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks 显示文摘Cohen SB Emery P Greenwald MW 2006Arthritis Rheum2006,54,:1
5Early life menstrual characteristics and pregnancy experiences among women with and without major depression:the Harvard study of moods and cycles显示文摘Harlow BL Cohen LS Otto MW 2004J Affective Disord2004,79,:1
6The expanding role of systemic therapy in head and neck cancer 显示文摘Cohen EE Lingen MW Vokes EE 2004J Clin Oncol2004,22,9:1
7Prevalence of body dysmorphic disorder in a community sample of women 显示文摘Otto MW Wilhelm S Cohen LS 2001Am J Psychiatry2001,158,:1
8Early appearance of neuronal contrbution to agrin-like molecules at embryonic frog nerve-muscle synapses formed in culture显示文摘Cohen MW Golfrey EW 1992Neurosci1992,12,8:1
9Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a muhicenter, randomized, double-blind, place- bo-controlled, phase Ⅲ trial evaluating primary efficacy and safety at twenty-four weeks显示文摘Cohen SB Emery P Greenwald MW 2006Arthritis Rheum2006,54,9:1
10Rituximab for rheu- matoid arthritis refractory to anti-tumor necrosis factor therapy: Re- suits of a multieenter, randomized, double-blind, placebo-con- trolled, phase m trial evaluating primary efficacy and safety at twenty-four weeks 显示文摘Cohen SB Emery P Greenwald MW 2006Arthritis Rheum2006,54,9:1
11A feed-forward loop involving protein kinase Calpha and microRNAs regulates tumor cell cycle显示文摘Cohen EE Zhu H Lingen MW 2009Cancer Res2009,69,1:1
12Prevalence and predictors of depressine symptoms in older pre-menopausal women显示文摘Harlow BL Cohen LS Otto MW 1999Arch Gen Psychiaty1999,56,5:1
13Rituximab for rhcumatoid arthritis refractory to anti-tumor necrosis factor therapy:results of a multicenter,randomized,double-blind,placebo-controlled,phase Ⅲ trial evaluating primary efficacy and safety at twenty-four weeks显示文摘Cohen SB Emcry P Greenwald MW 0,,09:1
14Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks 显示文摘Cohen SB Emery P Greenwald MW 2006Arthritis Rheum2006,54,9:1
15Cardiorespiratory fitness and the flexible modulation of cognitive control in preadolescent children显示文摘Pontifex MB Raine LB Johnson CR Chaddock L Voss MW Cohen NJ 0,,:1
16Links and impacts:The influence ofpublic research on industrial R&D 显示文摘Cohen MW Nelson RR Walsh P J 2002Management Science2002,48,1:1
17Chondral injury after arthroscopic meniscal repair using bioabsorbable Mitek Rapidloc meniscal fixation 显示文摘Cohen SB Anderson MW Miller MD 2003Arthroscopy2003,19,7:1
18The expanding role of systemic therapy in head and neck cancer显示文摘Cohen EE Lingen MW Vokes EE 0,,09:1
19The expanding role of systemic therapy in head and neck cancer显示文摘Cohen EE Lingen MW Vokes EE 2004J Clin Oneol2004,22,:1
20Rituximab for rheuma- toid arthritis refractory to anti-tumor necrosis factor therapy : Results of a muhicentcr, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks显示文摘Cohen SB Emery P Greenwald MW 2006Arthritis Rheum2006,54,9:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费